+880 18 4722 0014 (PMD)
+880 18 4722 0022 (Commercial)
+880 18 4722 0044 (HR)
info@teampharmabd.com
mkt@teampharmabd.com

Anitid 150 mg Tablet: Each film coated tablet contains Ranitidine 150 mg (as Ranitidine Hydrochloride BP).

Peptic ulcer (Duodenal ulcer & Gastric ulcer), Reflux esophagitis, Zollinger-Ellison syndrome, post operative ulcer and other conditions where reduction of gastric secretion and acid output is desirable, such as, the prophylaxis of gastrointestinal haemorrhage from stress ulceration in seriously ill patients, the prophylaxis of recurrent haemorrhage in patients with bleeding peptic ulcers and before general anaesthesia in patients considered to be at risk of acid aspiration (Mendelson's syndrome), particularly obstetric patients during labour.

Peptic ulcer: 150 mg twice daily with breakfast and at night or 300 mg as a single daily dose at night for 4 weeks.

Maintenance therapy: 150 mg at night.

Reflux esophagitis: 150 mg twice daily or 300 mg as a single daily dose at night for upto 8 weeks.

Zollinger- Ellison Syndrome: 150 mg 3 times daily and this may be increased if necessary to 6 g daily in divided dose.

Children: The recommended oral dose for the treatment of peptic ulcer in children is 2 mg/kg to 4 mg/kg twice daily to a maximum of 300 mg ranitidine per day.

Adverse effects of ranitidine are generally infrequent and minor. Headache, malaise, dizziness, constipation, nausea, abdominal pain and rash may occur. Mental confusion and hallucination have occurred in geriatric patients during Ranitidine therapy.

Anitid 150 mg Tablet: Box containing 10x10's tablets in Alu-Alu blister pack.




PRESCRIBING INFORMATION